Published by Zoomedia, Inc.
Zoomedia is a leading communications agency dedicated to increasing our clients' value through insightful and imaginative creative programs for the life sciences industry.
For questions or comments about this site, please contact hypeandhope@zoomedia.com.
©2008 Zoomedia, Inc.
All rights reserved.
Osiris Therapeutics Inc. said it plans to sell its Osteocel business to medical device maker NuVasive Inc. for $35 million in an up-front payment at the closing of the deal, and up to $50 million in future milestone payments.
>> Read the Story